|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.30 CNY | -5.32% |
|
+0.71% | -9.99% |
| 01/07 | Tranche Update on Tibet Rhodiola Pharmaceutical Holding Co.'s Equity Buyback Plan announced on December 18, 2025. | CI |
| 08/05 | Tibet Rhodiola Pharmaceutical Holding's board elects chairman | RE |
| Market Cap | 1.22TCr 179.87Cr 157.18Cr 145.05Cr 133.7Cr 251.99Cr 17TCr 257.58Cr 1.73TCr 681.89Cr 8.48TCr 675.48Cr 660.66Cr 29TCr | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 958.28Cr 141.38Cr 123.55Cr 114.01Cr 105.09Cr 198.07Cr 14TCr 202.47Cr 1.36TCr 535.97Cr 6.67TCr 530.94Cr 519.29Cr 23TCr | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | -5.32% | ||
| 1 week | +0.71% | ||
| Current month | +2.43% | ||
| 1 month | +4.08% | ||
| 3 months | -8.57% | ||
| 6 months | -13.01% | ||
| Current year | -9.99% |
| 1 week | 38 |  | 40.7 |
| 1 month | 34.8 | | 40.7 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 57.98 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 20/11/2014 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 25/10/2019 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 08/01/2015 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 08/01/2015 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 08/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.32% | +0.71% | -0.13% | -9.54% | 179.87Cr | |
| +0.85% | -0.80% | +52.79% | +159.97% | 1,05100Cr | |
| +1.23% | -1.53% | +54.58% | +59.41% | 61TCr | |
| +0.04% | +2.58% | +34.47% | +84.84% | 45TCr | |
| -0.16% | +1.09% | +30.79% | +22.10% | 33TCr | |
| -0.76% | -0.27% | +35.71% | +36.60% | 28TCr | |
| -0.59% | -0.56% | +22.56% | +17.24% | 26TCr | |
| +0.03% | +1.66% | -19.74% | -40.26% | 22TCr | |
| -1.42% | +0.80% | +24.27% | +57.85% | 20TCr | |
| -1.48% | +3.43% | +24.08% | +70.06% | 17TCr | |
| Average | -0.81% | +0.37% | +25.94% | +45.83% | 35.77TCr | |
| Weighted average by Cap. | -0.14% | +0.02% | +37.71% | +77.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 280.67Cr 41Cr 36Cr 33Cr 31Cr 58Cr 3.99TCr 59Cr 399.12Cr 156.98Cr 1.95TCr 155.51Cr 152.1Cr 6.72TCr | 298.15Cr 44Cr 38Cr 35Cr 33Cr 62Cr 4.24TCr 63Cr 423.98Cr 166.76Cr 2.07TCr 165.19Cr 161.57Cr 7.14TCr |
| Net income | 105.13Cr 16Cr 14Cr 13Cr 12Cr 22Cr 1.49TCr 22Cr 149.49Cr 59Cr 731.52Cr 58Cr 57Cr 2.52TCr | 94Cr 14Cr 12Cr 11Cr 10Cr 19Cr 1.33TCr 20Cr 133.37Cr 52Cr 652.64Cr 52Cr 51Cr 2.25TCr |
| Net Debt | -235.14Cr -35Cr -30Cr -28Cr -26Cr -49Cr -3.34TCr -50Cr -334.38Cr -131.52Cr -1.64TCr -130.28Cr -127.42Cr -5.63TCr | -260.88Cr -38Cr -34Cr -31Cr -29Cr -54Cr -3.71TCr -55Cr -370.98Cr -145.91Cr -1.82TCr -144.54Cr -141.37Cr -6.25TCr |
Employees
671
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | CN¥38.30 | -5.32% | 67,49,534 |
| 16/26/16 | CN¥40.45 | +0.95% | 77,66,404 |
| 15/26/15 | CN¥40.07 | +1.96% | 90,12,483 |
| 14/26/14 | CN¥39.30 | +1.39% | 62,46,346 |
| 13/26/13 | CN¥38.76 | +1.92% | 69,77,297 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
